The rapid tests of rennesens GmbH inclusive the reader
CardioDetect scan represent the product family of CardioDetect, which is made to detect or exclude the
existence of an AMI
Additional to h-FABP
it can detect the late marker Troponin in plasma.
Two marker on one test - at the right time with high sensitivity
The first test which can proof evidence of AMI for
the complete relevant period. The test takes it benefit from the marker combination of h-FABP
(heart-type fatty acid binding protein) and cardiac Troponin l.
Source:rennesens GmbH
h-FABP increases very shortly after the onset of AMI. It perfectly complements the traditional gold standard Troponin.